2019-09-20 10:24

Posting: # 20633
Views: 576

 Equivalency Studies for Injectables [Design Issues]


We're developing an injection product (solution, subcutaneous use).

During our developmental stages, we've changed some manufacturing parts and supplier in between.
We've conduct some clinical studies with the pre-changed product.

We want to conduct a comparative study with the previous product vs. the to-be-marketed product.
In the case for oral dosage forms, we would conduct a comparative dissolution study.

In the case for injection products, how would we show equivalency?
What kind of equivalency studies can we conduct?


Edit: Category changed; see also this post #1[Helmut]
 Admin contact
20,345 posts in 4,273 threads, 1,402 registered users;
online 10 (1 registered, 9 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 00:25 CET

The internet gave us all the power of speech,
and what did we discover?
That victory goes to he who shouts the loudest,
and that reason does not sell.    Claire North

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz